RxDoctor Payments Data

Tawnya Pfitzer, DPM

Podiatrist · Avondale, AZNPI 1609818095

Payments from drug & device makers

$518in general payments, 2019–2025

Across 15 payments — averaging $34.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • DJO, LLC$141
  • Rikco International, LLC$128
  • Nevro Corp.$98
  • Angiodynamics, Inc.$50
  • Amgen$46
  • Smith+Nephew$28
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$30058%
  • Education$21842%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
DJO, LLC3$141
Rikco International, LLC4$128
Nevro Corp.1$98
Angiodynamics, Inc.1$50
Amgen3$46
Smith+Nephew1$28
Kowa Pharmaceuticals America, Inc.1$16
Orthofix Medical, Inc.1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$518 in reported general payments places this provider in the 45th percentile of 151 podiatrist providers in Arizona.

See all podiatrist providers in Arizona

Medicare billing

Part B allowed, 2024
$108,344
Medicare patients
310
Services billed
1,178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl59$1,217
Gentamicin Sulfate12$1,055
Ciclopirox16$964
Diclofenac Sodium13$264
Cephalexin25$192

Paid to pharmacies, not to this prescriber.

Other podiatrist in Avondale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →